Cancer

March 20, 2026

Study shows AI-assisted risk model for lung nodules is cost-effective

Risk prediction software using artificial intelligence can help determine whether pulmonary nodules detected during lung cancer screening need to be biopsied.

By Tom Wilemon
(iStock image)
March 20, 2026

Precancerous blood disorder raises risk of inflammatory heart disease

New study suggests that treating patients for CHIP (clonal growth of precancerous blood cells) could reduce their risk of potentially life-threatening heart inflammation.

By Bill Snyder
March 10, 2026

Lung cancer conference set for May 8

Vanderbilt-Ingram Cancer Center and the Vanderbilt Lung Institute will host “The Future of Lung Cancer Care,” a one-day educational event scheduled for May 8 from 8:30 a.m. to 2:30 p.m. at the Nashville Marriott at Vanderbilt University.

By Tom Wilemon
March 5, 2026

Thyroid cancer ‘atlas’ points to cell types that contribute to disease progression

A multi-institutional study led by Vanderbilt Health investigators provides a spatial understanding of thyroid cancer evolution and identifies cell types that may predict aggressive disease in both children and adults.

By Evan Dorian
March 3, 2026

Vanderbilt Health and Bertis establish collaboration for cancer drug discovery

The collaboration will integrate Vanderbilt Health’s Molecular AI Initiative capabilities with Bertis’ deep proteomics and AI-enabled technologies to identify novel therapeutic targets and predictive biomarkers.

March 3, 2026

Study led by Monroe Carell Jr. Children’s Hospital at Vanderbilt looks at international cohort with rare cancer

Novel research is paving way for less invasive therapies for gliomas in pediatric patients.

By Jessica Pasley
February 27, 2026

Demographic and histologic factors influence risk of colon polyp recurrence

Vanderbilt Health study supports shift toward dynamic surveillance that extends monitoring for patients with specific demographic and histologic risk profiles.
By Leigh MacMillan
February 18, 2026

Patient with melanoma receives tumor-infiltrating lymphocyte therapy

The highly personalized treatment is currently approved for patients with advanced stages of melanoma whose tumors have grown despite immunotherapies and/or targeted therapies.
By Tom Wilemon
February 12, 2026

Vanderbilt Health celebrates milestone for novel histotripsy procedure 

Appealing to patients for its noninvasive nature, it avoids many of the traditional drawbacks of surgeries that use incisions, including pain management. 
By Evan Dorian
February 10, 2026

Wife of cholangiocarcinoma patient makes gift in honor of husband

After moving to Nashville in 2011, Sallie and John chose Vanderbilt Health for their care because they valued being part of a teaching hospital.
By Camille Amadeo Savell
February 4, 2026

Clinical trial led by Vanderbilt Health seeks to refine lung cancer biopsy standards

The development of better biopsy approaches is driven by the fact that lung cancer kills more than 130,000 Americans annually, and survival depends on early diagnosis, which requires biopsy to be definitive.
By Jill Clendening
January 12, 2026

Guide published for outpatient cancer treatment with bispecific antibodies

Vanderbilt-Ingram was among the first in the nation to establish outpatient protocols for another personalized immunotherapy, CAR-T.
By Tom Wilemon
January 8, 2026

Patients with clonal hematopoiesis have increased heart disease risk following cancer treatment 

Study supports the potential benefits of screening patients for CHIP before they undergo cancer treatment so they can be more closely monitored for heart complications.
By Tom Wilemon